Compliance, safety standards, and global frameworks every brand must navigate.
The first half of 2026 has delivered one of the densest periods of REACH-linked regulatory change for the cosmetics industry in recent years. From new SVHC candidate list additions to PFAS deadlines and Omnibus VI structural reforms, this compliance brief maps what has changed, who is affected, and what actions quality and regulatory teams must prioritise.
Commission Regulation (EU) 2023/1545 — the most significant change to fragrance allergen labelling in two decades — comes into force on 31 July 2026. There is no grace period for new products, and the compliance checklist is longer than most brands currently recognise.
The clean beauty movement is entering a new phase. Instead of focusing on ingredient exclusion lists, brands are increasingly prioritising scientific validation, safety assessments, and performance data to build consumer trust.
Commission Regulation (EU) 2023/1545 — the most significant change to fragrance allergen labelling in two decades — comes into force on 31 July 2026. There is no grace period for new products, and the compliance checklist is longer than most brands currently recognise.
The clean beauty movement is entering a new phase. Instead of focusing on ingredient exclusion lists, brands are increasingly prioritising scientific validation, safety assessments, and performance data to build consumer trust.
YSL Beauty's push towards refillable beauty products reflects a broader industry shift where sustainability is becoming a business imperative rather than a niche initiative. The move raises important questions for brands, manufacturers, and packaging suppliers navigating evolving regulatory and consumer expectations.
India's cosmetics regulatory framework has evolved significantly in recent years, yet industry discussions increasingly focus on a persistent challenge: enforcement. For compliant manufacturers and importers, the issue is becoming as important as the regulations themselves.
India's aesthetics sector is entering a new regulatory phase as CDSCO intensifies scrutiny of injectable cosmetic products. The move could have far-reaching implications for importers, distributors, clinics, and manufacturers operating in the fast-growing aesthetics market.
The US FDA has added bemotrizinol to its list of permitted sunscreen active ingredients, marking the first major sunscreen filter approval in approximately 20 years. The decision could reshape sunscreen formulation strategies, regulatory planning, and market opportunities for brands targeting the US market.
The UK's ASA ruled Beauty Pie's "clinically proven to reduce wrinkles" claim for its C-Wave LED mask was unsubstantiated, citing small sample size, no placebo group, and confounding co-products used during testing. For Indian beauty device and skincare brands, the specific evidentiary gaps identified are directly instructive.
An Illinois federal court has allowed a class action against MAC Cosmetics' virtual try-on technology to proceed, alleging facial geometry data was collected without informed consent. For Indian brands deploying AR try-on, AI skin scanning, or similar facial recognition tools, the compliance lessons are immediate.
YSL Beauty's push towards refillable beauty products reflects a broader industry shift where sustainability is becoming a business imperative rather than a niche initiative. The move raises important questions for brands, manufacturers, and packaging suppliers navigating evolving regulatory and consumer expectations.
India's cosmetics regulatory framework has evolved significantly in recent years, yet industry discussions increasingly focus on a persistent challenge: enforcement. For compliant manufacturers and importers, the issue is becoming as important as the regulations themselves.